Most recent articles by:

Editorial Team

- Advertisement -

AstraZeneca receives FDA approval for its Asthma drug AirSupra

AstraZeneca has successfully received approval for its Asthma therapy- AirSupra. AstraZeneca (AZ) representative stated that the FDA has authorised...

Fate, Century, and TCR2 Therapeutics make major cuts to staff and research

Fate, Century, and TCR2 Therapeutics have planned to reorganize in the new year signaling longer plans for cell therapy development for cancer.

Spectrum Labs Recalls Three Batches of Epinephrine Following Discoloration Complains

Spectrum Laboratory Products has voluntarily recalled all batches of epinephrine USP, a bulk API powder utilized in the production of the pharmaceutical...

Pfizer Steps Back From Early-Stage Rare Disease R&D

Pfizer is withdrawing from research and development for rare diseases in their initial phases. As part of a rethinking of its strategy...

CDC reports a new strain of omicron taking over the U.S.

CDC has warned of a new variant of omicron that has spread across the U.S. Concerns have been raised over the second...

Amazon Inches Closer to Acquiring One Medical

Amazon has moved closer to finalizing its $3.9 billion acquisition of One Medical after receiving approval from Oregon’s health agency.

Novartis pays $245 million to close Exforge lawsuit

Novartis has made the decision to resolve all legal pay-for-delay disputes by making final settlements. Novartis will pay a total of $245...

AstraZeneca teams up with G42 Healthcare to increase drug production in Abu Dhabi

AstraZeneca has signed a strategic partnership agreement with G42 Healthcare to manufacture medicinal therapies in Abu Dhabi. The agreement concentrates on teamwork...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC
- Advertisement -